Celera Diagnostics Announces Collaboration With Bristol-Myers Squibb to Study Cardiovascular Disease and Diabetes.

Extract


Celera Diagnostics Announces Collaboration With Bristol-Myers Squibb to Study Cardiovascular Disease and Diabetes.

Business Editors/Health & Medical Writers

BIOWIRE2K

ALAMEDA, Calif.--(BUSINESS WIRE)--Oct. 7, 2002

Celera Diagnostics, a 50/50 joint venture between the Applied Biosystems Group (NYSE:ABI) and the Celera Genomics Group (NYSE:CRA) of Applera Corporation, today announced a scientific collaboration with Bristol-Myers Squibb to study genes that may be useful in the d...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company